Rapid onset of antidepressant effects, mild and infrequent adverse effects, and cost-effectiveness position light therapy as an alternative to pharmacologic treatments for depression.
Researchers examined whether more severe appetitive symptoms predicted a positive response to light therapy.
The findings confirmed amplified emotionality associated with bipolar disorder and demonstrated fluctuations in different components of coping flexibility and mood states across time.
The 7 treatments included in the study were amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil.
The GDS-15 uses short sentences and a yes/no format, which is easier for patients who are struggling with depression, fatigue, or cognitive impairment to tolerate.
Investigators compare brain changes in PTSD because they could be associated with the comorbid major depressive disorder rather than the diagnosis of PTSD.
Quality of life has emerged as an important factor for research because it may be valuable to measure treatment outcomes.
Adolescents with bipolar I disorder whose symptoms are in remission are significantly less likely to experience conduct disorder or antisocial personality disorder.
Meditation techniques have an ever-growing evidence base to support their use and have become increasingly accepted in Western medicine as helpful adjuncts to other therapies.
Stigmatizing terms used to describe individuals who have a substance addiction, including “addict,” alcoholic,” and “substance abuser,” may be associated with negative explicit and implicit biases and should be replaced with positive terms that still describe the conditions accurately.
MHPAEA enforcement was positively associated with lower spending for mental illness treatment among those with parity-associated policies.